‌

US Patent 10829760 Nucleic acid molecules inducing RNA interference, and uses thereof

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

OliX Pharmaceuticals

Current Assignee

OliX Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 10, 2020

Patent Application Number

16220030

Date Filed

December 14, 2018

Patent Citations

US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof

US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3

US Patent 10064801 RNA complexes that inhibit melanin production

US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor

US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1

Patent Citations Received

US Patent 11446394 Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery

US Patent 11701434 Tertiary amino lipidated cationic peptides for nucleic acid delivery

0

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10829760 Nucleic acid molecules inducing RNA interference, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.